Back
Return
Biography

Dr. Ziyaur Rahman

Food and Drug Administration, India


Email: ziyaur.rahman@fda.hhs.gov


Qualifications

2005 Ph.D., Hamdard University, Pharmaceutics

2002 Master, Hamdard University, Pharmacy

2001 Bachelor, Hamdard University, Pharmacy


Publications (selected)

  1. Korang-Yeboah M, Sohail A, Siddiqui A, Rahman Z, Khan MA. Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product. Drug Dev Ind Pharm. 2015.
  2. Rahman Z, Mohammad A, Sohail A, Siddiqui A, Korang-Yeboah M, Khan MA. Chemometric model development and comparison of Raman and 13C ssNMR-chemometric methods for quantification of crystalline/amorphous warfarin sodium fraction in the formulations. J Pharm Sci. 2015.
  3. Rahman Z, Mohammad A, Siddiqui A, Khan MA. Comparison of Univariate and Multivariate Models of 13C SSNMR and XRPD Techniques for Quantification of Nimodipine Polymorphs. AAPS PharmSciTech. 2015.
  4. Rahman Z, Bykadi S, Siddiqui A, Khan MA. Comparison of X-ray Powder Diffraction and Solid-State Nuclear Magnetic Resonance in Estimating Crystalline Fraction of Tacrolimus in Sustained-Release Amorphous Solid Dispersion and Development of Discriminating Dissolution Method. J Pharm Sci. 2015 May; 104 (5): 1777-86.
  5. Ahmad MZ, Ahmad J, Amin S, Rahman M, Anwar M, Mallick N, Ahmad FJ, Rahman Z, Kamal MA, Akhter S. 2014. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease. CNS Neurol Disord Drug Targets. 13 (8): 1315-24.
  6. Rahman Z, Siddiqui A, Bykadi S, Khan MA. 2014. Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized x-ray powder diffraction method with chemometrics. Int J Pharm. 475 (1-2): 462-470.
  7. Siddiqui A, Rahman Z, Khan SR, Awotwe-Otoo D, Khan MA. 2014. Root cause evaluation of particulates in the lyophilized indomethacin sodium trihydrate plug for parenteral administration. Int J Pharm. 473 (1-2): 545-51.
  8. Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA. 2014. Development of performance matrix for generic product equivalence of acyclovir topical creams. Int J Pharm. 475 (1-2): 110-122.
  9. Rahman Z, Siddiqui A, Bykadi S, Khan MA. 2014. Near-Infrared and Fourier Transform Infrared Chemometric Methods for the Quantification of Crystalline Tacrolimus from Sustained-Release Amorphous Solid Dispersion. J Pharm Sci. June 103 (8): 2376-85.
  10. Siddiqui A, Rahman Z, Khan MA. 2014. Application of chemometric methods to differential scanning calorimeter (DSC) to estimate nimodipine polymorphs from cosolvent system. Drug Dev Ind Pharm. 26: 1-5.
  11. Siddiqui A, Rahman Z, Bykadi S, Khan MA. 2014. Chemometric Methods for the Quantification of Crystalline Tacrolimus in Solid Dispersion by Powder X-Ray Diffractrometry. J Pharm Sci. 103 (9): 2819-28.
  12. Rahman Z, Xu X, Katragadda U, Krishnaiah YS, Yu L, Khan MA. 2014. Quality by Design Approach for Understanding the Critical Quality Attributes of Cyclosporine Ophthalmic Emulsion. Mol Pharm. 11 (3): 787-99.
  13. Rahman Z, Khan MA. 2013. Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approach. Int J Pharm. 455 (1-2): 113-23.
  14. Rahman Z, Siddiqui A, Khan MA. 2013. Characterization of a Nonribosomal Peptide Antibiotic Solid Dispersion Formulation by Process Analytical Technologies Sensors. J Pharm Sci. 102 (12): 4337-46.
  15. Siddiqui A, Rahman Z, Sayeed VA, Khan MA. 2013. Chemometric Evaluation of Near Infrared, Fourier Transform Infrared, and Raman Spectroscopic Models for the Prediction of Nimodipine Polymorphs. J Pharm Sci. 102 (11): 4024-35.
  16. Rahman Z, Khan MA. 2013. Hunter screening design to understand the product variability of solid dispersion formulation of a peptide antibiotic. Int J Pharm. 456 (2): 572-82.
  17. Akhter S, Ahmad MZ, Ahmad FJ, Rahman Z, Bhatnagar A, Storm G. 2013. Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits. Eur J Nanomed.
  18. Bhanushali C, Zidan AS, Rahman Z, Habis MJ. 2013. Ion pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles. AAPS PharmSciTech. 14 (4): 1313-20.
  19. Rahman Z, Akhtar S, Khan MA. 2013. Orally disintegrating tablet of novel salt of antiepileptic drug: Formulation strategy and evaluation. Eur J Pharm Biopharm. 85 (3 Pt B): 1300-9.
  20. Akhter S, Ahmad MZ, Singh A, Ahmad I, Rahman Z, Ahmad FJ, Storm G, Kok RJ. 2013. Nanomedicines as cancer therapeutics: current status. Curr Cancer Drug Targets. 13 (4): 362-78.
  21. Rahman M, beg S, Ahmad MZ, Kazmi I, Ahmed A, Rahman Z, FJ Ahmad, Akhter S. 2013. Omega-3 fatty acids as pharmacotherapeutics in psoriasis: current status and scope of nanomedicine in its effective delivery. Curr Drug Targets. 14 (6): 708-22.
  22. Ahmad MZ, Akhter S, Rahman Z, Akhter S, Anwar M, Mallik N, Ahmad FJ. 2013. Nanometric gold in cancer nanotechnology: current status and future prospect. J Pharm Pharmacol. 65 (5): 634-51.
  23. Shamsher AAA, Charoo NA, Rahman Z, Kohli K, Krishna Pillai. 2013. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations. Pharm Dev Technol.
  24. Ibrahim HM, Ahmed TA, Hussain MD, Rahman Z, Samy AM, Kaseem AA, Nutan MTH. 2013. Development of meloxicam in-situ implant formulation by Quality by Design principle. Drug Dev Ind Pharm.
  25. Rahman Z, Zidan AS, Khan SR, Reddy IK, Khan MA. 2012. Cholorpheniramine Tannate Complexes: Physicochemical, chemometric, and taste masking evaluation. Int J Pharm. 436 (1-2): 582-92.

Profile Details

Null